Redmile Group

Venture Capital

Portfolio

companies

By category

BioTech£30.0M

By location

Cambridge£30.0M

Portfolio companies

Sphere Fluidics

Sphere Fluidics develops single cell analysis and characterisation systems for biopharmaceutical discovery.

Team

Rob Faulkner

Rob serves as Managing Director at Redmile Group and holds board positions at several companies, including Impulse Dynamics, Genalyte, Sphere Fluidics, and Saluda Medical.

Recent investments

Series B28 October 2021

£30.0M

Sphere Fluidics raises £30m in Series B funding to accelerate international sales and product development.

BioTech

The investment round was co-led by Sofinnova Partners and Redmile Group to fund global expansion and research programmes.

"This is a transformational investment from two of the most respected specialist investment funds in the industry and a recognition of the untapped potential of the pioneering product and market development carried out by the Company to date"

— Andrew Mackintosh, Chairman

Sphere Fluidics—Cambridge, UKFollow

Sofinnova Partners + 1 other